TRIACIN-C- triprolidine and pseudoephedrine hydrochlorides and codeine phosphate syrup syrup United States - English - NLM (National Library of Medicine)

triacin-c- triprolidine and pseudoephedrine hydrochlorides and codeine phosphate syrup syrup

sti pharma llc - triprolidine hydrochloride (unii: yan7r5l890) (triprolidine - unii:2l8t9s52qm), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - triprolidine hydrochloride 1.25 mg in 5 ml - triacin-c is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. triacin-c is contraindicated under the following conditions: codeine sulfate is contraindicated for postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy. this drug should not be used in newborn or premature infants. antihistamines should not be used to treat lower respiratory tract symptoms, including asthma. hypersensitivity to (1) codeine phosphate or other narcotics; (2) triprolidine hydrochloride or other antihistamines of similar chemical structure; or (3) sympathomimetic amines, including pseudoephedrine. sympathomimetic amines are contraindicated in patients with severe hypertension, severe coronary artery disease and in patients on monoamine oxidase (mao) inhibitor therapy (see precautions - drug interactions ). like other medications containing a narcotic, triacin-c is controlled by the drug enforcemen

TRIPROLIDINE HYDROCHLORIDE- triprolidine hydrochloride liquid United States - English - NLM (National Library of Medicine)

triprolidine hydrochloride- triprolidine hydrochloride liquid

strides pharma inc - triprolidine hydrochloride (unii: yan7r5l890) (triprolidine - unii:2l8t9s52qm) - antihistamine - temporarily relieves: runny nose sneezing itching of nose and throat itchy, watery eyes due to hay fever or other upper respiratory allergies or allergic rhinitis - runny nose - sneezing - itching of nose and throat - itchy, watery eyes due to hay fever or other upper respiratory allergies or allergic rhinitis - if you or your children are taking sedatives or tranquilizers, without first consulting your doctor - with any other product containing triprolidine - glaucoma - a breathing problem such as emphysema or chronic bronchitis - difficulty in urination due to enlargement of the prostate gland - nervousness, dizziness or sleeplessness occurs - symptoms do not improve within 7 days or are accompanied by a fever

TRIPRODINE SYRUP Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

triprodine syrup

royce pharma manufacturing sdn. bhd. - triprolidine hydrochloride; pseudoephedrine hydrochloride -

ZUTRIPRO- hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride solution United States - English - NLM (National Library of Medicine)

zutripro- hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride solution

hawthorn pharmaceuticals, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - zutripro is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients less than 6 years of age [see contraindications (4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve zutripro for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. zutripro is contraindicated for: - all children younger than 6 years of age [see warnings and precautions (5.2), use in specific populations (8.4) ]. zutripro is also contraindicated in patients with: - significant respiratory depression [see warnings and pre